跳至主要内容
临床试验/NCT03476954
NCT03476954已完成不适用

Perfusion Enhancement With Respiratory Impedance in Stroke (PERI-Stroke)

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in CBF that occurs during RI, as measured by diffuse correlation spectroscopy (DCS) with a sampling frequency of 5 Hz

研究概览

简要总结

This is a non-randomized phase 2 study designed to asses the mean flow velocity (MFV) and cerebral blood flow (CBF) response to non-invasive respiratory impedance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • Ability and willingness to sign informed consent by patient or legally acceptable surrogate decision maker
  • Acute ischemic stroke within 72 hours of study enrollment
  • Imaging or examination confirming unilateral frontal lobe involvement in the stroke

排除标准

  • Hemorrhagic conversion of ischemic infarct
  • History or presence of congestive heart failure, as defined by any of the following:
  • Any preceding diagnosis of congestive heart failure as per patient report or medical record
  • Report of moderate or severe systolic or diastolic dysfunction on prior
  • Reduced ejection fraction, <50%, on prior echocardiogram
  • Jugular venous pulsations >10 cm
  • Pulmonary edema on chest radiography Of note, an echocardiogram is not required prior to study enrollment.
  • History or presence of cardiomyopathy, as per medical record, patient report, or prior echocardiogram
  • History or presence of pneumothorax or hemothorax
  • History or presence of COPD
  • History of current use of home oxygen
  • Presence of pneumonia, as clinically determined by the primary medical team after admission chest radiography
  • Age < 18 years
  • Skull defect that would interfere with CBF monitoring
  • Pregnancy (urine or serum testing will required prior to enrollment of any pre-menopausal women)
  • Structural brain lesion, including known primary tumor, metastatic tumor, or vascular malformation
  • Prior neurosurgical procedure
  • Any medical condition that the clinical investigator feels would pose a hazard to the subject if he/she participated in the study

研究组 & 干预措施

Respiratory impedance monitoring session

Experimental

干预措施: Respiratory Impedance (RI) (Other)

结局指标

主要结局

Change in CBF that occurs during RI, as measured by diffuse correlation spectroscopy (DCS) with a sampling frequency of 5 Hz

时间窗: Baseline

Reports of any of the following: shortness of breath, chest pain, fatigue, or hypoxia

时间窗: Baseline

次要结局

  • Change in end-tidal carbon dioxide (CO2), during RI(Baseline)
  • Change in mean arterial pressure (MAP,) during RI(Baseline)
  • Change in National Institute of Health Stroke Scale (NIHSS) (admission vs discharge)(Baseline)
  • Time to maximum CBF effect after the introduction of RI(Baseline)
  • Change in MFV as measured by transcranial doppler (TCD), during RI(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven Messe

Associate Professor of Neurology

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验

Perfusion Enhancement With Respiratory Impedance in... | 临床试验